scholarly journals Antagonist-mediated down-regulation of toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus

2012 ◽  
Vol 14 (2) ◽  
pp. R80 ◽  
Author(s):  
Shui-Lian Yu ◽  
Paul KS Chan ◽  
Chun-Kwok Wong ◽  
Cheuk-Chun Szeto ◽  
Suzanne C Ho ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Toll Like Receptors ◽  
Systemic Lupus ◽  
Down Regulation ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection

Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus

Lupus ◽  
2014 ◽  
Vol 24 (6) ◽  
pp. 606-612 ◽  
Author(s):  
M García-Carrasco ◽  
C Mendoza-Pinto ◽  
P Munguía-Realpozo ◽  
A Rodríguez-Gallegos ◽  
V Vallejo-Ruiz ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Hydroxyvitamin D ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
25 Hydroxyvitamin D ◽  
Cervical Human Papillomavirus

scholarly journals Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: Association with human papillomavirus infection

2004 ◽  
Vol 50 (11) ◽  
pp. 3619-3625 ◽  
Author(s):  
Lai-Shan Tam ◽  
Alice Y. K. Chan ◽  
Paul K. S. Chan ◽  
Alexander R. Chang ◽  
Edmund K. Li
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Squamous Intraepithelial Lesions ◽  
Systemic Lupus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Intraepithelial Lesions

SAT0022 Lack of Association between Serum 25-Hydroxyvitamin D Concentrations and Cervical Human Papillomavirus Infection in Systemic Lupus Erythematosus

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 597.1-597
Author(s):  
C. Mendoza-Pinto ◽  
M. García-Carrasco ◽  
S. Méndez-Martínez ◽  
V. Vallejo-Ruiz ◽  
A. Taboada-Cole ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Hydroxyvitamin D ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
25 Hydroxyvitamin D ◽  
Cervical Human Papillomavirus

scholarly journals Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review

2010 ◽  
Vol 30 (5) ◽  
pp. 665-672 ◽  
Author(s):  
Iuri Usêda Santana ◽  
Alline do Nascimento Gomes ◽  
Leomar D’Cirqueira Lyrio ◽  
Maria Fernanda Rios Grassi ◽  
Mittermayer Barreto Santiago
Keyword(s):  
Systematic Review ◽  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Malignant Lesions

scholarly journals The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus

Clinics ◽  
2013 ◽  
Vol 68 (12) ◽  
pp. 1475-1480 ◽  
Author(s):  
C Mendoza-Pinto ◽  
M Garcia-Carrasco ◽  
V Vallejo-Ruiz ◽  
A Taboada-Cole ◽  
M Muñoz-Guarneros ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Infection Risk ◽  
Systemic Lupus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Anti Cd20 ◽  
The Impact ◽  
Cervical Human Papillomavirus

Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women

Lupus ◽  
2017 ◽  
Vol 26 (9) ◽  
pp. 944-951 ◽  
Author(s):  
C Mendoza-Pinto ◽  
M García-Carrasco ◽  
V Vallejo-Ruiz ◽  
S Méndez-Martínez ◽  
A Taboada-Cole ◽  
...  
Keyword(s):  
Risk Factors ◽  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Odds Ratio ◽  
Systemic Lupus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Cyclophosphamide Dose ◽  
Cumulative Prevalence

Objectives Our objective was to study the incidence, persistence and clearance of human papillomavirus infection in systemic lupus erythematosus women and assess risk factors for persistence of human papillomavirus infection. Methods We carried out a prospective, observational cohort study of 127 systemic lupus erythematosus women. Patients were evaluated at baseline and at three years. Traditional and systemic lupus erythematosus women-related disease risk factors were collected. Gynaecological evaluations and cervical cytology screening were made. Human papillomavirus detection and genotyping were made by polymerase chain reaction and linear array. Results The cumulative prevalence of human papillomavirus infection increased from 22.8% at baseline to 33.8% at three years; p = < 0.001: 20.1% of patients experienced 43 incident infections. The risk of any human papillomavirus infection was 10.1 per 1000 patient-months. At three years, 47 (88.6%) prevalent infections were cleared. Independent risk factors associated with incident human papillomavirus infection included more lifetime sexual partners (odds ratio = 1.8, 95% confidence interval = 1.11–3.0) and cumulative cyclophosphamide dose (odds ratio = 3.9, 95% confidence interval = 1.2–12.8). Conclusions In systemic lupus erythematosus women, the cumulative prevalence of human papillomavirus infection, including high risk-human papillomavirus and multiple human papillomavirus infections, may increase over time. Most persistent infections were low risk-human papillomavirus. The number of lifetime sexual partners and the cumulative cyclophosphamide dose were independently associated with incident human papillomavirus infection.

Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis

Lupus ◽  
2011 ◽  
Vol 21 (4) ◽  
pp. 365-372 ◽  
Author(s):  
W Rojo-Contreras ◽  
EM Olivas-Flores ◽  
JI Gamez-Nava ◽  
H Montoya-Fuentes ◽  
B Trujillo-Hernandez ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Mexican Women ◽  
Systemic Lupus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Cervical Human Papillomavirus

scholarly journals Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus

2012 ◽  
Vol 33 (2) ◽  
pp. 335-340 ◽  
Author(s):  
Leomar D. C. Lyrio ◽  
Maria Fernanda R. Grassi ◽  
Iuri U. Santana ◽  
Viviana G. Olavarria ◽  
Aline do N. Gomes ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Cervical Human Papillomavirus

Risk of systemic lupus erythematosus in patients with human papillomavirus infection: a population-based retrospective cohort study

Lupus ◽  
2018 ◽  
Vol 27 (14) ◽  
pp. 2279-2283 ◽  
Author(s):  
L-H Shi ◽  
J-Y Huang ◽  
Y-Z Liu ◽  
J-Y Chiou ◽  
R Wu ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Human Papillomavirus ◽  
Lupus Erythematosus ◽  
Hpv Infection ◽  
Population Based ◽  
Systemic Lupus ◽  
Insurance Program ◽  
Papillomavirus Infection ◽  
Hazard Ratios ◽  
Insurance Database

Background: Viral infection contributing to systemic lupus erythematosus (SLE) development has been largely reported. However, the SLE risk in patients with human papillomavirus (HPV) infection is unknown. Methods: Data were retrieved from the Longitudinal Health Insurance Database (2000) in Taiwan. We identified 43,567 patients with HPV infection and 174,268 age- and sex-matched uninfected controls from 2002 to 2012. Individuals were followed up from index date (first date of diagnosis with HPV) until the occurrence of SLE, at the end of the study (December 2013), or when they were withdrawn from the insurance program. The incidence rate ratio (IRR) was calculated using the univariate Poisson regression. The adjusted hazard ratios (aHRs) were calculated, and sensitive and subgroups analyses were also conducted. Results: Compared with the non-HPV controls, the IRR of SLE in HPV patients was 1.52 (95% confidence interval (CI): 1.09–2.12). The risk of SLE in HPV-infected individuals was significantly high (aHR: 1.48, 95% CI: 1.06–2.06) after adjusting for age, sex, and comorbidities. Men aged between 16 and 45 years were more susceptible to developing SLE (aHR: 21.57, 95% CI: 2.52–184.60, p = 0.0051). Conclusion: Our study showed a significantly higher risk of SLE among HPV-infected patients, especially in men aged between 16 and 45 years.

Expression of Toll-like receptors 2 and 4 in the saliva of patients with systemic lupus erythematosus and chronic periodontitis

2021 ◽  
Author(s):  
Consuelo P. C. Marques ◽  
Vandilson P. Rodrigues ◽  
Larissa C. de Carvalho ◽  
Louise P. Nichilatti ◽  
Mayra M. Franco ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Chronic Periodontitis ◽  
Toll Like Receptors ◽  
Systemic Lupus
Sign in / Sign up

Export Citation Format

Share Document